These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 24678881)

  • 1. The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis?
    Genovese F; Manresa AA; Leeming DJ; Karsdal MA; Boor P
    Fibrogenesis Tissue Repair; 2014 Mar; 7(1):4. PubMed ID: 24678881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold.
    Bülow RD; Boor P
    J Histochem Cytochem; 2019 Sep; 67(9):643-661. PubMed ID: 31116062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of genetics and epigenetics to progression of kidney fibrosis.
    Tampe B; Zeisberg M
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv72-9. PubMed ID: 23975750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profiling of urinary extracellular vesicles in chronic kidney disease and renal fibrosis.
    Tepus M; Tonoli E; Verderio EAM
    Front Pharmacol; 2022; 13():1041327. PubMed ID: 36712680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Turnover of type III collagen reflects disease severity and is associated with progression and microinflammation in patients with IgA nephropathy.
    Genovese F; Boor P; Papasotiriou M; Leeming DJ; Karsdal MA; Floege J
    Nephrol Dial Transplant; 2016 Mar; 31(3):472-9. PubMed ID: 26311218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and urine markers of collagen degradation reflect renal fibrosis in experimental kidney diseases.
    Papasotiriou M; Genovese F; Klinkhammer BM; Kunter U; Nielsen SH; Karsdal MA; Floege J; Boor P
    Nephrol Dial Transplant; 2015 Jul; 30(7):1112-21. PubMed ID: 25784725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum markers of liver fibrosis: combining the BIPED classification and the neo-epitope approach in the development of new biomarkers.
    Veidal SS; Bay-Jensen AC; Tougas G; Karsdal MA; Vainer B
    Dis Markers; 2010; 28(1):15-28. PubMed ID: 20164543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular serum markers of liver fibrosis.
    Liu T; Wang X; Karsdal MA; Leeming DJ; Genovese F
    Biomark Insights; 2012; 7():105-17. PubMed ID: 22872786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic kidney disease induced by an adenine rich diet upregulates integrin linked kinase (ILK) and its depletion prevents the disease progression.
    de Frutos S; Luengo A; García-Jérez A; Hatem-Vaquero M; Griera M; O'Valle F; Rodríguez-Puyol M; Rodríguez-Puyol D; Calleros L
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1284-1297. PubMed ID: 30726718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Understanding the Effects of Erythropoietin on Renal Fibrosis.
    Zhang Y; Zhu X; Huang X; Wei X; Zhao D; Jiang L; Zhao X; Du Y
    Front Med (Lausanne); 2020; 7():47. PubMed ID: 32154256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia causes important changes of extracellular matrix biomarkers and ADAMTS proteinases in the adriamycin-induced renal fibrosis model.
    Armutcu F; Demircan K; Yildirim U; Namuslu M; Yagmurca M; Celik HT
    Nephrology (Carlton); 2019 Aug; 24(8):863-875. PubMed ID: 30719800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of chronic renal disease in humans is associated with the deposition of basement membrane components and decorin in the interstitial extracellular matrix.
    Vleming LJ; Baelde JJ; Westendorp RG; Daha MR; van Es LA; Bruijn JA
    Clin Nephrol; 1995 Oct; 44(4):211-9. PubMed ID: 8575119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can renal fibrosis be reversed?
    Eddy AA
    Pediatr Nephrol; 2005 Oct; 20(10):1369-75. PubMed ID: 15947978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel biomarker of laminin turnover is associated with disease progression and mortality in chronic kidney disease.
    Holm Nielsen S; Guldager Kring Rasmussen D; Brix S; Fenton A; Jesky M; Ferro CJ; Karsdal M; Genovese F; Cockwell P
    PLoS One; 2018; 13(10):e0204239. PubMed ID: 30273365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein degradation fragments as diagnostic and prognostic biomarkers of connective tissue diseases: understanding the extracellular matrix message and implication for current and future serological biomarkers.
    Genovese F; Karsdal MA
    Expert Rev Proteomics; 2016; 13(2):213-25. PubMed ID: 26689914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique changes in interstitial extracellular matrix composition are associated with rejection and cyclosporine toxicity in human renal allograft biopsies.
    Abrass CK; Berfield AK; Stehman-Breen C; Alpers CE; Davis CL
    Am J Kidney Dis; 1999 Jan; 33(1):11-20. PubMed ID: 9915262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous Extracellular Matrix Accumulation in a Human in vitro Model of Renal Fibrosis Is Mediated by αV Integrins.
    Bon H; Hales P; Lumb S; Holdsworth G; Johnson T; Qureshi O; Twomey BM
    Nephron; 2019; 142(4):328-350. PubMed ID: 31048591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Renal Fibrosis-Turning Challenges into Opportunities.
    Klinkhammer BM; Goldschmeding R; Floege J; Boor P
    Adv Chronic Kidney Dis; 2017 Mar; 24(2):117-129. PubMed ID: 28284377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICAM-1 interactions in the renal interstitium: a novel activator of fibroblasts during nephritis.
    Clayton A; Steadman R
    Histol Histopathol; 1999 Jul; 14(3):861-70. PubMed ID: 10425556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and assessment of renal fibrosis: the state of the art.
    Berchtold L; Friedli I; Vallée JP; Moll S; Martin PY; de Seigneux S
    Swiss Med Wkly; 2017; 147():w14442. PubMed ID: 28634969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.